Correction: Role of novel histone modifications in cancer
Metrics: PDF 1884 views | ?
1Department of Pharmacology, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore
2Stem Cell and Cancer Biology Laboratory, School of Biomedical Sciences, Curtin Health Innovation Research Institute, Curtin University, Perth, WA, Australia
3Department of Botany and Microbiology, College of Science, King Saud University, Riyadh, Kingdom of Saudi Arabia
4Division of Cancer Stem Cells and Cardiovascular Regeneration, School of Regenerative Medicine, Manipal Academy of Higher Education (MAHE), Bangalore, India
5Cancer Science Institute of Singapore, National University of Singapore, Singapore, Singapore
6Curtin Medical School, Faculty of Health Sciences, Curtin University, Perth, WA, Australia
7National University Cancer Institute, National University Health System, Singapore, Singapore
8Department of Biological Sciences, University of North Texas, Denton, Texas, USA
9College of Korean Medicine, Kyung Hee University, Dongdaemun-gu, Seoul, Korea
10Institute of Molecular and Cell Biology, A*STAR, Biopolis Drive, Proteos, Singapore, Singapore
11Department of Pathology, National University Hospital Singapore, Singapore, Singapore
Published: April 10, 2018
This article has been corrected: The correct author name is given below:
Original article: Oncotarget. 2018; 9:11414-11426. DOI: https://doi.org/10.18632/oncotarget.23356.
All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 3.0 License.